Biomarker strategies: the diagnostic and management process of patients with suspected AMI

Diagnosis (Berl). 2016 Dec 1;3(4):167-173. doi: 10.1515/dx-2016-0026.

Abstract

Security standards of our times largely exclude a discharge of patients with chest pain from the emergency departments (EDs) based on clinical assessment alone. Given the increasing use and consequently crowding of EDs worldwide and the large proportion of patients who present to the EDs with, however vague, signs and symptoms of acute coronary syndrome, there is a strong clinical and public health need to achieve a faster but safe rule-in and rule-out of acute myocardial infarction (AMI) to direct patients onto the correct management pathway. A number of approaches for a faster rule-in and rule-out of AMI are currently under research and evaluation and some have already been integrated into current guidelines and/or implemented into the clinical routine in selected centers. This article summarizes these different diagnostic strategies for patients with suspected AMI, using cardiac troponin alone or in combination with copeptin.

Keywords: acute coronary syndrome (ACS); acute myocardial infarction (AMI); copeptin; rule-in; rule-out; troponin.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acute Coronary Syndrome / blood
  • Acute Coronary Syndrome / diagnosis
  • Acute Disease
  • Adult
  • Biomarkers / blood
  • Chest Pain / diagnosis*
  • Chest Pain / etiology
  • Electrocardiography
  • Emergency Service, Hospital / statistics & numerical data
  • Glycopeptides / blood*
  • Humans
  • Male
  • Myocardial Infarction / blood
  • Myocardial Infarction / diagnosis*
  • Myocardial Infarction / epidemiology
  • Patient Discharge
  • Predictive Value of Tests
  • Risk Assessment
  • Troponin T / blood*

Substances

  • Biomarkers
  • Glycopeptides
  • Troponin T
  • copeptins